FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

NASA - 13848 - Aerospace Medicine and Occupational Health Advisory Committee - Agency Authority

GENERAL INFORMATION

Committee Name	Aerospace Medicine and Occupational Health Advisory Committee	Agency Name	National Aeronautics and Space Administration
Fiscal Year	2005	Committee Number	13848
Original Establishment Date	4/24/1997	Committee Status	Terminated
Actual Termination Date	9/20/2005	Committee URL
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	Unlimited
Terminated This FY	Yes	Designated Fed Officer Position Title*	Administrative Officer
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	4/29/2005	Designated Federal Officer First Name*	Pamela
Date Of Renewal Charter	4/29/2007	Designated Federal Officer Middle Name	R
Projected Termination Date		Designated Federal Officer Last Name*	Barnes
Exempt From Renewal*	No	Designated Federal Officer Suffix
Specific Termination Authority	NASA Strategic Management Council, Meeting Minutes	Designated Federal Officer Phone*	202-358-1954
Establishment Authority*	Agency Authority	Designated Federal Officer Fax*	202-258-3349
Specific Establishment Authority*	Public Law 85-568, As Amended, Section 203 (c)(7)	Designated Federal Officer Email*	pamela.r.barnes@nasa.gov
Effective Date Of Authority*	4/24/1997
Exempt From EO 13875 Discretionary Cmte
Committee Type*	Continuing
Presidential*	No
Committee Function*	Other Committee

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	No
Legislation Status	Enacted
How does cmte accomplish its purpose?*	The Aerospace Medicine and Occupational Health Advisory Committee (AMOHAC)advised the NASA Administrator through the NASA Advisory Council (NAC) on Agency policies, programs and plans relative to NASA’s responsibilities for aerospace medicine and occupational health. In aerospace medicine, Committee responsibilities broadly included advising NASA on all health and medical practice as well as health related research requirements and direction in support of human space flight. In occupational health, Committee advice covered compliance with externally mandated statutory requirements and the provision of effective health services for employees.
How is membership balanced?*	At least one member of the Office of Biological and Physical Research Advisory Committee, the Space Flight Advisory Committee, and the Aerospace Safety Advisory Panel was appointed to the Committee to ensure robust communication and integration between these advisory groups on all matters affecting health. Membership was balanced with experts representing aerospace medicine, occupational health, clinical medicine practice, and medical management.
How frequent & relevant are cmte mtgs?*	Estimated number of meetings per year: 2. Estimated total meetings: 6.
Why advice can't be obtained elsewhere?*	The Committee advised the NASA Administrator on crucial, uncharted areas impacting short and long distance space travel and made recommendations shaping the strategic and tactical direction of Agency occupational health, improving return on investment and performance-based decision making in the human capital arena. The collective Committee expertise in such selective areas as atmospheric and space flight, occupational health epidemiological tracking, clinical research in support of space medicine, the practice of medicine in extreme environments, bioethics, and medical practice development is not sufficiently resident within NASA. NASA requires consensus advice from experts in these disciplines to optimize the execution of our broad range of related responsibilities.
Why close or partially close meetings?
Recommendation Remarks	This advisory committee was terminated as part of the overall NASA advisory committee restructuring effort that took place during 2005.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	Yes
Outcome Trust In Government	No	Action Reallocate Resources	No
Outcome Major Policy Changes	No	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	Yes
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	Yes	Action Comment	NA
Outcome Implement Laws/Reg Requirements	Yes	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment	NA	Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	Cost savings is unknown.	Grants Review Comment	NA
Number Of Recommendations*	11	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	Recommendations included the following: 1) the role of AMOHAC as a policy advisory panel; 2) the need for R&D activities to continue to follow the DoD acquisition model by using peer review/program review/portfolio management principles; 3) refinements of the Transition to Medical Practice (TMP); 4) ways of augmenting potential community of commercial and university contributors to the bioastronautics Roadmap; 5) research and development for the completion of the Crew Exploration Vehicle (CEV); 6) deliverables that allow flexibility to accommodate improvements in medical prevention, diagnostics, pharmacology, and intervention; 7) a process to identify standards, requirements and deliverables to ensure prevention, health maintenance for ground workforce, and additional medical intervention for astronauts; 8) the inclusion of medical decision makers in the design teams of the CEV; 9) continuation of ways to provide appropriate reproductive services for astronauts; 10) implementation of a comprehensive health program for astronauts and their families; and 11) the appropriation of resources for hardware, software refinement, and personnel to deploy an electronic health record system for occupational medicine.	Access Agency Website	No
% of Recs Fully Implemented*	81.00%	Access Committee Website	No
% of Recs Fully Implemented Comment	Recommendations 2, 3, 4, 5, 6, 7, 8, 10, and 11 are expected to be fully implemented.	Access GSA FACA Website	No
% of Recs Partially Implemented*	0.00%	Access Publications	No
% of Recs Partially Implemented Comment	NA	Access Other	No
Agency Feedback*	Yes	Access Comment	Committee information and documentation resides in the Office of the Chief Health and Medical Officer with the DFO.
Agency Feedback Comment*	The Committee Chair presented findings and recommendations at the NASA Advisory Committee (NAC)for disposition.	Narrative Description*	NASA is obligated to its stakeholders to meet the intent of the National Aeronautics and Space Act of 1958, which established the Agency for the purpose of expanding human knowledge for the benefit of all humankind. As such, NASA employs a process of checks and balances, including health and medical policy direction, technical requirements and standards to maximize health protection within mission constraints at all levels, and to assist NASA in focusing on biomedical research efforts. The Committee drew on the expertise of its members and other sources to provide advice and made recommendations to the Chief Health and Medical Officer on plans, policies, programs, and other matters pertinent to the Agency’s responsibilities for aerospace medicine and occupational health, including direction and requirements of clinical research in support of human space flight, standards for health and medical practice, and medical and ethical standards for human and animal research and clinical practice.

COSTS

1. Payments to Non-Federal Members*	$0.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$0.00
2. Payments to Federal Members*	$0.00	2. Est. Payments to Fed Members Next FY*	$0.00
3. Payments to Federal Staff*	$0.00	3. Estimated Payments to Federal Staff*	$0.00
4. Payments to Consultants*	$0.00	4. Est. Payments to Consultants Next FY*	$0.00
5. Travel Reimb. For Non-Federal Membrs*	$1,782.00	5. Est Travel Reimb Non-Fed Membr nxtFY*	$0.00
6. Travel Reimb. For Federal Members*	$0.00	6. Est Travel Reimb For Fed Members*	$0.00
7. Travel Reimb. For Federal Staff*	$0.00	7. Est. Travel Reimb to Fed Staf Nxt FY*	$0.00
8. Travel Reimb. For Consultants*	$0.00	8. Est Travel Reimb to Consltnts Nxt FY*	$0.00
10. Other Costs	$225.00	10. Est. Other Costs Next FY*	$0.00
11. Total Costs	$2,007.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified		Est. Fed Staff Support Next FY*	0.00
Federal Staff Support (FTE)*	0.00	Est Cost Remarks
Cost Remarks

Interest Areas

No interest areas selected for this committee.

Custom Links

Committee Level Reports